Home
Trade News  |  February 28, 2022
Media

Jeffrey DeAlmeida appointed new Senior Vice President of BASF Pharma Solutions

  • Highly experienced leader brings a passion for innovation and teamwork to growing business unit

FLORHAM PARK, NJ, February 28, 2022 – BASF Corporation today announced the appointment of Jeffrey DeAlmeida to the role of Senior Vice President, Pharma Solutions and Nutrition & Health Americas, effective March 1, 2022. He succeeds Christian Seufert, who has decided to transition to a role outside the company.

In this role, Jeffrey DeAlmeida takes responsibility for BASF’s global pharmaceutical solutions portfolio and the Nutrition & Health business in North and South America.

Jeffrey DeAlmeida has served in numerous leadership roles and brings over 23 years of experience working in multinational organizations in the automotive industry, in both OEM and tier supplier roles. He joined BASF’s Catalyst Division in 2001 after four years with DaimlerChrysler Corporation. He has held numerous roles within BASF, including Global Key Account Manager for Commercial Truck OEMs in North America, Global Product Manager for gasoline engine applications, marketing management for the Americas region and management of the Mobile Emissions Catalyst division in South America. His most recent role was as Vice President of Transportation for BASF’s Performance Materials business, leading customer-facing commercial and technical teams serving the automotive industry, as well as key initiatives in the areas of Diversity, Equity and Inclusion and Sustainability.

Jeffrey DeAlmeida holds a Master of Business Administration from New York University, a Master of Science in Mechanical Engineering from the University of Michigan and a Bachelor of Science in Mechanical Engineering from Pennsylvania State University.

Throughout his career, Jeffrey DeAlmeida has been driven by a passion for innovation, teamwork and tackling tough challenges, as well as creating an empowering, inclusive, high-growth environment where people can truly succeed.

“I am excited to be taking this next step in my career at BASF. It’s an honor to join the team at Pharma Solutions and Nutrition & Heath, especially during this time when we are creating opportunities for innovation, operational excellence and exceptional customer experience across the entire business with cutting edge digital tools. My experience has uniquely prepared me to lead organizations in this environment and I’m grateful for the opportunity to be part of this incredibly dynamic team,” states Jeffrey DeAlmeida.

 

About BASF’s Nutrition & Health division

BASF Nutrition & Health provides a comprehensive product and service range for human and animal nutrition, pharmaceutical, bioenergy and flavor & fragrance industries. With our science-driven portfolio, we address customers in globally growing markets to meet the demands of an expanding world population. Together with our customers, we play an active role in enhancing the nutrition, health and wellbeing of consumers all over the world. Our products fulfill the highest safety, regulatory and sustainability standards. BASF Nutrition & Health operates sites in Europe, North America, South America and in Asia-Pacific. For more information, go to www.basf.com.

 

About BASF

At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 111,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €78.6 billion in 2021. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the U.S. Further information at www.basf.com.

 

P-22-151

 

Deb Oliveri
Deb Oliveri
Nutrition & Pharma Solutions
Rebekka-Martina Müller
Media Relations Nutrition & Health
Last Update February 28, 2022